- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CPAP therapy reduces all-cause and cardiovascular mortality in OSA patients: Lancet

A new study published in The Lancet Respiratory Medicine journal showed positive airway pressure (PAP) treatment to be associated with reduced mortality rates in obstructive sleep apnea (OSA) patients.
There is conflicting information on how positive airway pressure treatment for obstructive sleep apnea affects mortality from all causes. Adam Benjafield and team therefore set out to explore the hypothesis that PAP treatment is linked to lower cardiovascular and all-cause mortality in individuals with OSA in this systematic review and meta-analysis.
Without regard to language or location, this study conducted a search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials for this systematic review and meta-analysis from the beginning of the database until August 22, 2023 (updated September 9, 2024). Abstracts from recent conferences (2022–2023) and reference lists of relevant works were also examined. This research excluded studies that evaluated only PAP adherence and other study types.
Also, outpatient studies (confounder-adjusted, non-randomized controlled studies [NRCSs] or randomised controlled trials [RCTs]) that assessed the incidence of cardiovascular mortality, all-cause mortality, or both in adults (aged ≥18 years) with OSA who were treated versus not treated with PAP were included. To estimate overall HRs and 95% CIs, this study used a linear random-effects model to analyze each log-transformed hazard ratio (HR) and SE. By employing Newcastle–Ottawa Scale for NRCSs and the Cochrane Risk of Bias tool for RCTs, this study assessed the risk of bias.
A total of 30 studies (ten RCTs and twenty NRCSs) were included in the systematic review and meta-analysis after 435 of the 5484 records found by our search were evaluated for eligibility. These studies comprised 11,75,615 individuals, with a mean age of 59·5 (SE 1·4) years and a mean follow-up of 5·1 (0·5) years.
Of these, 9,05,224 (77%) were male and 2,70,391 (23%) were female (SE 1·9). The bias was a low to moderate risk. The clinically meaningful benefit of PAP treatment increased with usage, and the risk of cardiovascular mortality and all-cause mortality was considerably lower in the PAP group than in the no-PAP group. Overall, these findings supported a possible positive impact of PAP treatment on cardiovascular and all-cause mortality in OSA patients.
Reference:
Benjafield, A. V., Pepin, J.-L., Cistulli, P. A., Wimms, A., Lavergne, F., Sert Kuniyoshi, F. H., Munson, S. H., Schuler, B., Reddy Badikol, S., Wolfe, K. C., Willes, L., Kelly, C., Kendzerska, T., Johnson, D. A., Heinzer, R., Lee, C.-H., Malhotra, A., & medXcloud Group. (2025). Positive airway pressure therapy and all-cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies. The Lancet. Respiratory Medicine. https://doi.org/10.1016/S2213-2600(25)00002-5
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751